Join
Live feed
·
INSIDERFilingvia Quantisnow
PhaseBio Pharmaceuticals Inc. logo

SEC Form 4: Thorp Clay bought $30,000 worth of Common Stock (10,000 units at $3.00), increasing direct ownership by 44% to 32,943 units

ByQuantisnow·Wall Street's wire, on your screen.
PHAS· PhaseBio Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHAS (PhaseBio Pharmaceuticals Inc.) and more on Quantisnow.